SMN2 and proximal spinal muscular atrophy: The dosage of SMN2, a neighboring nearly identical gene, has been identified as a potent modifier of SMA severity: a copy number of SMN2 of ≥ 4 is highly predictive of achieving the ability to walk (SMA type III/IV) [3].